{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T03:51:20Z","timestamp":1772250680024,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T00:00:00Z","timestamp":1453939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Heart Journal"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.ihj.2015.09.013","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T10:03:36Z","timestamp":1447149816000},"page":"S57-S60","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S1","title":["Levosimendan. A promising future drug for refractory cardiac failure in children?"],"prefix":"10.1016","volume":"68","author":[{"given":"Supriya","family":"Kushwah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashutosh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.S.","family":"Sahana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ihj.2015.09.013_bib0055","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.bcp.2004.05.018","article-title":"Potassium-specific effects of levosimendan on heart mitochondria","volume":"68","author":"Kopustinskiene","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ihj.2015.09.013_bib0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(97)01108-4","article-title":"Levosimendan a novel Ca2+ sensitizer, activates the glibenclamide-sensitive K+ channel in rat arterial myocytes","volume":"333","author":"Yokoshiki","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ihj.2015.09.013_bib0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.PCC.0000235251.14491.75","article-title":"Early experience with levosimendan in children with ventricular dysfunction","volume":"7","author":"Namachivayam","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ihj.2015.09.013_bib0070","doi-asserted-by":"crossref","first-page":"465","DOI":"10.5414\/CPP40465","article-title":"Pharmacokinetics of levosimendan and its metabolites during and after a 24-hour continuous infusion in patients with severe heart failure","volume":"40","author":"Kivikko","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.ihj.2015.09.013_bib0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.2165\/00003495-200161050-00006","article-title":"Levosimendan","volume":"61","author":"Figgitt","year":"2001","journal-title":"Drugs"},{"key":"10.1016\/j.ihj.2015.09.013_bib0080","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0014-2999(01)01350-4","article-title":"Levosimendan is a mitochondrial KATP channel opener","volume":"428","author":"Kopustinskiene","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ihj.2015.09.013_bib0085","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/PCC.0b013e3182455571","article-title":"Levosimendan versus milrinone in neonates and infants after corrective open heart surgery: a pilot study","volume":"13","author":"Lechner","year":"2012","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ihj.2015.09.013_bib0090","first-page":"139","article-title":"Levosimendan, a new inotropic drug: experience in children with acute heart failure","volume":"107","author":"Magliola","year":"2009","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.ihj.2015.09.013_bib0095","first-page":"23","article-title":"Intensive care for newborns and babies of the first year of life with acute heart failure after cardiosurgical interventions","volume":"5","author":"Lobacheva","year":"2010","journal-title":"Anesteziol Reanimatol"},{"key":"10.1016\/j.ihj.2015.09.013_bib0100","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.amjcard.2004.01.073","article-title":"Effects of levosimendan on circulating pro-inflammatory cytokines and soluble apoptosis mediators in patients with decompensated advanced heart failure","volume":"93","author":"Parissis","year":"2004","journal-title":"Am J Cardiol"}],"container-title":["Indian Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215004095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0019483215004095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T16:02:32Z","timestamp":1545926552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0019483215004095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":10,"alternative-id":["S0019483215004095"],"URL":"https:\/\/doi.org\/10.1016\/j.ihj.2015.09.013","relation":{},"ISSN":["0019-4832"],"issn-type":[{"value":"0019-4832","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levosimendan. A promising future drug for refractory cardiac failure in children?","name":"articletitle","label":"Article Title"},{"value":"Indian Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ihj.2015.09.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Cardiological Society of India. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}